Svenja Kiljan1, Paolo Preziosa2, Laura E Jonkman3, Wilma Dj van de Berg3, Jos Twisk4, Petra Jw Pouwels5, Geert J Schenk1, Maria A Rocca6, Massimo Filippi7, Jeroen Jg Geurts1, Martijn D Steenwijk1. 1. Department of Anatomy & Neurosciences, Amsterdam UMC, locatie VU University Medical Center, Amsterdam, The Netherlands/Amsterdam Neuroscience, MS Center Amsterdam, Amsterdam, The Netherlands. 2. Department of Anatomy & Neurosciences, Amsterdam UMC, locatie VU University Medical Center, Amsterdam, The Netherlands/Amsterdam Neuroscience, MS Center Amsterdam, Amsterdam, The Netherlands/Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, and Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. 3. Department of Anatomy & Neurosciences, Amsterdam UMC, locatie VU University Medical Center, Amsterdam, The Netherlands. 4. Department of Epidemiology and Biostatistics, Amsterdam UMC, locatie VU University Medical Center, Amsterdam, The Netherlands. 5. Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, MS Center Amsterdam, Amsterdam UMC, locatie VU University Medical Center, Amsterdam, The Netherlands. 6. Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, and Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. 7. Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, Neurology Unit, Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy/Vita-Salute San Raffaele University, Milan, Italy.
Abstract
BACKGROUND: Neuroaxonal degeneration is one of the hallmarks of clinical deterioration in progressive multiple sclerosis (PMS). OBJECTIVE: To elucidate the association between neuroaxonal degeneration and both local cortical and connected white matter (WM) tract pathology in PMS. METHODS: Post-mortem in situ 3T magnetic resonance imaging (MRI) and cortical tissue blocks were collected from 16 PMS donors and 10 controls. Cortical neuroaxonal, myelin, and microglia densities were quantified histopathologically. From diffusion tensor MRI, fractional anisotropy, axial diffusivity (AD), radial diffusivity (RD), and mean diffusivity (MD) were quantified in normal-appearing white matter (NAWM) and white matter lesions (WML) of WM tracts connected to dissected cortical regions. Between-group differences and within-group associations were investigated through linear mixed models. RESULTS: The PMS donors displayed significant axonal loss in both demyelinated and normal-appearing (NA) cortices (p < 0.001 and p = 0.02) compared with controls. In PMS, cortical axonal density was associated with WML MD and AD (p = 0.003; p = 0.02, respectively), and NAWM MD and AD (p = 0.04; p = 0.049, respectively). NAWM AD and WML AD explained 12.6% and 22.6%, respectively, of axonal density variance in NA cortex. Additional axonal loss in demyelinated cortex was associated with cortical demyelination severity (p = 0.002), explaining 34.4% of axonal loss variance. CONCLUSION: Reduced integrity of connected WM tracts and cortical demyelination both contribute to cortical axonal loss in PMS.
BACKGROUND:Neuroaxonal degeneration is one of the hallmarks of clinical deterioration in progressive multiple sclerosis (PMS). OBJECTIVE: To elucidate the association between neuroaxonal degeneration and both local cortical and connected white matter (WM) tract pathology in PMS. METHODS: Post-mortem in situ 3T magnetic resonance imaging (MRI) and cortical tissue blocks were collected from 16 PMS donors and 10 controls. Cortical neuroaxonal, myelin, and microglia densities were quantified histopathologically. From diffusion tensor MRI, fractional anisotropy, axial diffusivity (AD), radial diffusivity (RD), and mean diffusivity (MD) were quantified in normal-appearing white matter (NAWM) and white matter lesions (WML) of WM tracts connected to dissected cortical regions. Between-group differences and within-group associations were investigated through linear mixed models. RESULTS: The PMS donors displayed significant axonal loss in both demyelinated and normal-appearing (NA) cortices (p < 0.001 and p = 0.02) compared with controls. In PMS, cortical axonal density was associated with WML MD and AD (p = 0.003; p = 0.02, respectively), and NAWM MD and AD (p = 0.04; p = 0.049, respectively). NAWM AD and WML AD explained 12.6% and 22.6%, respectively, of axonal density variance in NA cortex. Additional axonal loss in demyelinated cortex was associated with cortical demyelination severity (p = 0.002), explaining 34.4% of axonal loss variance. CONCLUSION: Reduced integrity of connected WM tracts and cortical demyelination both contribute to cortical axonal loss in PMS.
Entities:
Keywords:
Multiple sclerosis; axonal loss; histopathology; magnetic resonance imaging; post mortem; progressive
Authors: S Mesaros; M A Rocca; K Kacar; J Kostic; M Copetti; T Stosic-Opincal; P Preziosa; S Sala; G Riccitelli; M A Horsfield; J Drulovic; G Comi; M Filippi Journal: Neurology Date: 2012-02-29 Impact factor: 9.910
Authors: Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona Journal: Nat Methods Date: 2012-06-28 Impact factor: 28.547
Authors: Eric C Klawiter; Robert E Schmidt; Kathryn Trinkaus; Hsiao-Fang Liang; Matthew D Budde; Robert T Naismith; Sheng-Kwei Song; Anne H Cross; Tammie L Benzinger Journal: Neuroimage Date: 2011-01-13 Impact factor: 6.556
Authors: Massimiliano Calabrese; Roberta Magliozzi; Olga Ciccarelli; Jeroen J G Geurts; Richard Reynolds; Roland Martin Journal: Nat Rev Neurosci Date: 2015-03 Impact factor: 34.870
Authors: Anand J C Eijlers; Quinten van Geest; Iris Dekker; Martijn D Steenwijk; Kim A Meijer; Hanneke E Hulst; Frederik Barkhof; Bernard M J Uitdehaag; Menno M Schoonheim; Jeroen J G Geurts Journal: Brain Date: 2018-09-01 Impact factor: 13.501
Authors: Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith Journal: Neuroimage Date: 2011-09-16 Impact factor: 6.556
Authors: Klaus Schmierer; Claudia A M Wheeler-Kingshott; Phil A Boulby; Francesco Scaravilli; Daniel R Altmann; Gareth J Barker; Paul S Tofts; David H Miller Journal: Neuroimage Date: 2006-12-16 Impact factor: 6.556
Authors: James Kolasinski; Charlotte J Stagg; Steven A Chance; Gabriele C Deluca; Margaret M Esiri; Eun-Hyuk Chang; Jacqueline A Palace; Jennifer A McNab; Mark Jenkinson; Karla L Miller; Heidi Johansen-Berg Journal: Brain Date: 2012-10 Impact factor: 13.501
Authors: Matthias Bussas; Sophia Grahl; Viola Pongratz; Achim Berthele; Christiane Gasperi; Till Andlauer; Christian Gaser; Jan S Kirschke; Benedikt Wiestler; Claus Zimmer; Bernhard Hemmer; Mark Mühlau Journal: Mult Scler Date: 2021-09-30 Impact factor: 5.855
Authors: Michelle Zuo; Naomi M Fettig; Louis-Philippe Bernier; Elisabeth Pössnecker; Shoshana Spring; Annie Pu; Xianjie I Ma; Dennis Sw Lee; Lesley A Ward; Anshu Sharma; Jens Kuhle; John G Sled; Anne-Katrin Pröbstel; Brian A MacVicar; Lisa C Osborne; Jennifer L Gommerman; Valeria Ramaglia Journal: JCI Insight Date: 2022-06-22
Authors: Graham Cooper; Claudia Chien; Hanna Zimmermann; Judith Bellmann-Strobl; Klemens Ruprecht; Joseph Kuchling; Susanna Asseyer; Alexander U Brandt; Michael Scheel; Carsten Finke; Friedemann Paul Journal: Mult Scler Date: 2021-04-15 Impact factor: 6.312